Home

Slough Estates to Develop 780,000 sq ft Campus for Genetech in California


Dec 20, 2004

Slough Estates plc, a leading provider of flexible business space, today announced that Genentech, Inc. (NYSE: DNA) has agreed to terms with Slough Estates USA Inc to lease approximately 780,000 square feet of office and laboratory space in eight new buildings on its Britannia East Grand site, South San Francisco. Genentech proposes to integrate the development with its existing campus in South San Francisco.

Slough's construction will take place in two phases over a four-year period and is estimated to cost over $325 million.

The master-planned campus project will be funded from the proceeds of selective asset sales by Slough Estates USA Inc., which is now established as a self-financing part of the Group.

Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs.

Ian Coull, Chief Executive of Slough Estates commented: "We believe the lease agreement with Genentech to extend their campus onto our Britannia East Grand site reinforces Slough's position as the pre-eminent developer and brand leader of life sciences facilities in California. We have a successful history of working with our clients to deliver a market-leading product in the rapidly expanding life sciences industry. Our strategy to recycle assets selectively to fund further development evidences Slough Estates' commitment to delivering maximum shareholder value from our asset portfolio."

For further information contact:

Slough Estates plc
Ian Coull, Chief Executive
Tel: 01753 537171

Shared Value Limited
Andrew Best / Emily Bruning
Tel: 020 7321 5022 / 5027

Slough Estates is a leading provider of flexible business space in business parks in Western Europe and North America, with over 1700 customers occupying 2.9 million square metres of business space, with a total value of £3.6 billion. Slough Estates' properties are in suburban locations in close proximity to the main business centres, where there is long-term demand for business accommodation to serve these key economic regions. The company's main activities are currently based around London, Brussels, Paris, Düsseldorf, San Francisco and San Diego and the company continues to develop new business parks with the long term objective of building shareholder value and enhancing its reputation for quality buildings offering excellent value to customers.


More Information
2004  
Land Securities and Slough Estates Complete Property Swap16 Dec 2004
Slough Estates Agrees Sale of Quail West for a net $57.5 Million02 Dec 2004
Appointment of Deputy Finance Director23 Nov 2004
Land Securities and Slough Estates Agree Property Swap15 Nov 2004
Slough Estates' Associate Tipperary Corp Settles Litigation04 Nov 2004
Pfizer Buys Life Sciences Campus from Slough Estates for $372 Million02 Nov 2004
Slough Estates exits Canada with C$80m sale28 Oct 2004
Slough Estates Wins Best Industrial Development Award22 Oct 2004
Slough's Bath Road Office Wins British Council Award14 Oct 2004
Slough Estates on Site Again at Parkbury04 Oct 2004
Farnborough Business Park - Historic Core Launch22 Sep 2004
Reorganisation of Continental European Business14 Sep 2004
Interim Results for the Six Months Ended 30 June 200426 Aug 2004
Land Securities and Slough Estates Agree Property Swap24 Aug 2004
Slough Estates wins Major Investor Relations Award22 Jun 2004
Slough Estates plc Annual General Meeting11 May 2004
Slough Estates Plc and Helios Properties form New Development Company08 Apr 2004
Preliminary Results for the Year Ended 31 December 200317 Mar 2004
Slough Estates Appoints Two New Non-Executive Directors28 Jan 2004